Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Black Diamond Therapeutics Inc BDTX

Healthcare Biotechnology
Black Diamond Therapeutics, Inc. is a clinical-stage oncology company focused on the development of MasterKey therapies that address families of oncogenic mutations in clinically validated targets. The Company’s MasterKey therapies are designed to address broad genetically defined patient populations, overcome resistance, minimize wild-type mediated toxicities, and be brain penetrant to treat... see more

Recent & Breaking News (NDAQ:BDTX)

Black Diamond Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire November 7, 2023

Black Diamond Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update

GlobeNewswire November 6, 2023

Black Diamond Therapeutics Presents Dose Escalation Data Demonstrating Durable Responses in Patients with NSCLC from Phase 1 Trial of BDTX-1535

GlobeNewswire October 14, 2023

Black Diamond Therapeutics to Present Preclinical and Clinical Data at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

GlobeNewswire October 4, 2023

Black Diamond Therapeutics Announces CEO Transition

GlobeNewswire September 18, 2023

Black Diamond Therapeutics Announces First Patients Dosed in Phase 1 Clinical Trial Expansion Cohorts Evaluating BDTX-1535 in Patients with Intrinsic Driver and Acquired Resistance EGFR Mutation Positive Non-Small Cell Lung Cancer

GlobeNewswire September 11, 2023

Black Diamond Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire September 5, 2023

Black Diamond Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update

GlobeNewswire August 11, 2023

Black Diamond Therapeutics Announces Pricing of Public Offering of Common Stock

GlobeNewswire June 29, 2023

Black Diamond Therapeutics Announces Proposed Public Offering of Common Stock

GlobeNewswire June 28, 2023

Black Diamond Therapeutics Announces Initial Dose Escalation Data Demonstrating Anti-Tumor Activity of BDTX-1535 in Non-Small Cell Lung Cancer Patients Across Multiple EGFR Mutation Families

GlobeNewswire June 27, 2023

Black Diamond Therapeutics Announces Promotion of Melanie Morrison to Chief Development Officer

GlobeNewswire June 13, 2023

Black Diamond Therapeutics to Present at the Jefferies Healthcare Conference

GlobeNewswire June 2, 2023

Black Diamond Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update

GlobeNewswire May 9, 2023

Black Diamond Therapeutics to Present at the Stifel 2023 Targeted Oncology Days

GlobeNewswire April 18, 2023

Black Diamond Therapeutics Presents Trial in Progress Poster for BDTX-1535 and Preclinical Data on BDTX-1535 and BDTX-4933 at the 2023 American Association of Cancer Research Annual Meeting

GlobeNewswire April 17, 2023

Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update

GlobeNewswire March 9, 2023

Black Diamond Therapeutics to Present at the Cowen 43rd Annual Health Care Conference

GlobeNewswire February 27, 2023

Black Diamond Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference

GlobeNewswire January 5, 2023

Black Diamond Therapeutics Announces Changes to Board of Directors

GlobeNewswire December 19, 2022